OUTCOMES OF WARFARIN THERAPY - LESSONS FROM THE REAL-WORLD

被引：9

作者：

BEYTH, RJ

LANDEFELD, CS

机构：

来源：

MAYO CLINIC PROCEEDINGS | 1995年 / 70卷 / 08期

关键词：

D O I：

10.4065/70.8.806

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：806 / 808

页数：3

共 16 条

[1]

[Anonymous], 1994, LANCET, V343, P687

[2]

Beyth R. J., 1995, JGIM, V10, P39

[3] CANADIAN ATRIAL-FIBRILLATION ANTICOAGULATION (CAFA) STUDY [J].

CONNOLLY, SJ ;

LAUPACIS, A ;

GENT, M ;

ROBERTS, RS ;

CAIRNS, JA ;

JOYNER, C .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :349-355

[4] WARFARIN IN THE PREVENTION OF STROKE ASSOCIATED WITH NONRHEUMATIC ATRIAL-FIBRILLATION [J].

EZEKOWITZ, MD ;

BRIDGERS, SL ;

JAMES, KE ;

CARLINER, NH ;

COLLING, CL ;

GORNICK, CC ;

KRAUSESTEINRAUF, H ;

KURTZKE, JF ;

NAZARIAN, SM ;

RADFORD, MJ ;

RICKLES, FR ;

SHABETAI, R ;

DEYKIN, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) :1406-1412

[5] RISK-FACTORS FOR COMPLICATIONS OF CHRONIC ANTICOAGULATION - A MULTICENTER STUDY [J].

FIHN, SD ;

MCDONELL, M ;

MARTIN, D ;

HENIKOFF, J ;

VERMES, D ;

KENT, D ;

WHITE, RH .

ANNALS OF INTERNAL MEDICINE, 1993, 118 (07) :511-520

[6] AGING AND THE ANTICOAGULANT RESPONSE TO WARFARIN THERAPY [J].

GURWITZ, JH ;

AVORN, J ;

ROSSDEGNAN, D ;

CHOODNOVSKIY, I ;

ANSELL, J .

ANNALS OF INTERNAL MEDICINE, 1992, 116 (11) :901-904

[7] ORAL ANTICOAGULANTS - MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE [J].

HIRSH, J ;

DALEN, JE ;

DEYKIN, D ;

POLLER, L .

CHEST, 1992, 102 (04) :S312-S326

[8]

LANDEFELD CS, 1989, AM J MED, V87, P144

[9] ANTICOAGULANT-RELATED BLEEDING - CLINICAL EPIDEMIOLOGY, PREDICTION, AND PREVENTION [J].

LANDEFELD, CS ;

BEYTH, RJ .

AMERICAN JOURNAL OF MEDICINE, 1993, 95 (03) :315-328

[10]

PETERSEN P, 1989, LANCET, V1, P175

← 1 2 →